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Abstract
 
Vascular aging is mainly characterized by endothelial dysfunction. We found decreased free ni-
tric oxide (NO) levels in aged rat aortas, in conjunction with a sevenfold higher expression and
activity of endothelial NO synthase (eNOS). This is shown to be a consequence of age-associ-
 
ated enhanced superoxide (
 
?
 
O
 
2
 
2
 
) production with concomitant quenching of NO by the for-
mation of peroxynitrite leading to nitrotyrosilation of mitochondrial manganese superoxide dis-
mutase (MnSOD), a molecular footprint of increased peroxynitrite levels, which also increased
with age. Thus, vascular aging appears to be initiated by augmented 
 
?
 
O
 
2
 
2
 
 release, trapping of
vasorelaxant NO, and subsequent peroxynitrite formation, followed by the nitration and inhibi-
tion of MnSOD. Increased eNOS expression and activity is a compensatory, but eventually fu-
tile, mechanism to counter regulate the loss of NO. The ultrastructural distribution of 3-nitro-
tyrosyl suggests that mitochondrial dysfunction plays a major role in the vascular aging process.
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Introduction
 
Cardiovascular diseases increase in frequency with age,
even in the absence of established risk factors (1). This sug-
gests that aging by itself alters vascular function. The endo-
thelium exerts a multimodal regulation of vascular smooth
muscle tone and structure by the release of nitric oxide
(NO),
 
1 
 
endothelium-derived hyperpolarizing factor, and
 
prostacyclin. NO is generated from 
 
L
 
-arginine catalyzed by
NO synthases (2, 3). One of these isoenzymes, endothelial
NO synthase (eNOS), is constitutively expressed in endo-
thelial cells (4). This enzyme is largely membrane associated
as a result of NH
 
2
 
-terminal myristoylation (5), a reaction
which regulates enzymatic biological activity (6, 7).
Endothelium-dependent relaxation declines with in-
creasing age (8). The underlying cellular and molecular
mechanisms associated with age-related endothelial dys-
function have not been elucidated, but might involve: (a)
changes in expression and/or activity of eNOS (9), (b) in-
creased breakdown of NO due to an augmented produc-
tion of superoxide anions (
 
?
 
O
 
2
 
2
 
 [10]), or (c) a gradual loss
of antioxidant capacity (11), which normally provides cel-
lular protection against reactive oxygen species.
The role of the 
 
L
 
-arginine/NO pathway in the patho-
physiology of vascular aging is controversial. Both reduced
levels of eNOS mRNA (12) and increased eNOS enzyme
expression combined with reduced activity (9) have been
reported. Therefore, our first aim was to clarify whether
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ible NOS; MnSOD, manganese superoxide dismutase; NO, nitric oxide;
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age-associated endothelial dysfunction is causally related to
alterations of the 
 
L
 
-arginine/NO system. To this end, mo-
lecular analyses of eNOS expression and its subcellular lo-
calization, which might affect the biological activity of this
enzyme system, were performed in aortas from young (4–6
mo), middle-aged (19 mo), and old (32–35 mo) rats and
correlated to direct measurements of NO production and
vascular function.
Reactive oxygen species and especially 
 
?
 
O
 
2
 
2
 
 are impor-
tant modulators of NO activity under various pathophysio-
logical conditions (13) and are thought to be involved in
the aging process (14). In this context it seemed essential to
assess the role of 
 
?
 
O
 
2
 
2
 
, which might scavenge NO to form
the powerful oxidant peroxynitrite (15, 16). In vivo
 
 
 
gener-
ation of peroxynitrite has not been directly demonstrated to
date (16). Unlike 
 
?
 
O
 
2
 
2
 
 (pK 4.8), peroxynitrite (with a pK
of 6.8) can easily penetrate cells in the protonated form be-
cause of its high diffusibility across phospholipid membranes
(17). Peroxynitrite is known to initiate oxidative modifica-
tion of proteins, including the nitration of aromatic rings
(18), sulfoxidation of methionin, and 
 
S
 
-nitrosylation of cys-
teine followed by disulfide formation, thereby rendering in-
active certain functionally important regulatory proteins,
like receptors or enzymes (19). Nitration of tyrosine is the
underlying mechanism of prostacyclin synthase inhibition
by peroxynitrite (20). Evidence for the in vivo formation of
peroxynitrite has been derived from immunohistochemical
detection of nitrotyrosine in human atherosclerotic lesions
(21) and in the tissue of rejected human renal allografts (22).
Recent indirect evidence (23) suggests that specific enzymes
may selectively accumulate oxidative damage during aging.
This is supported by a recent study demonstrating increased
nitration of the sarcoplasmic reticular Ca-ATPase isolated
from the skeletal muscle of 28-mo-old F344 rats (24).
Our second aim was to test the hypothesis that increased
nitration of protective, antioxidant enzymes, leading to
their inactivation with age, might be a contributing molec-
ular pathway for oxidative damage to vascular tissue. We
will show that the reduced endothelium-dependent relax-
ation associated with aging is not due to downregulation of
eNOS but rather to increased inactivation of NO by 
 
?
 
O
 
2
 
2
 
entailing altered NO bioavailability, as NO is removed
through the formation of peroxynitrite. The evidence for a
close association between the formation of peroxynitrite
and age-associated vascular endothelial dysfunction pro-
vided in this study is further strengthened by the demon-
stration of a selective nitration of manganese superoxide
dismutase (MnSOD) with increased age. The paradoxical
increase in eNOS expression and activity appears to be a
compensatory mechanism attempting to counteract in-
creased NO inactivation by 
 
?
 
O
 
2
 
2
 
.
 
Materials and Methods
 
Materials
 
Acetylcholine chloride, calcium ionophore A23187, sodium
nitroprusside (SNP), and 
 
N
 
G
 
-monomethyl-
 
l
 
-arginine (L-NMMA)
 
were all from Sigma-Aldrich. 
 
l
 
-[
 
14
 
C]arginine was purchased from
Amersham Pharmacia Biotech and tetrahydrobiopterin from
Schircks Laboratories.
 
Animals
 
F1 (F344 
 
3 
 
BN) healthy male rats, fed ad libitum, were ob-
tained from the National Institutes of Health, National Institute
on Aging (Bethesda, MD). The colonies are maintained under
contractual arrangement with Harlan Sprague Dawley, Inc. All
studies were performed in three different age groups: 4–6-mo-
old (“young”), 19-mo-old (“middle-aged”), and 32–35-mo-old
(“old”) rats. Heart rate and systolic arterial blood pressure were
measured in conscious animals using the tail-cuff method with a
custom-made pulse pressure transducer, and the mean of five in-
dependent determinations was calculated.
 
Surgical Procedures
 
On the day of the experiment, rats were anesthetized with keta-
mine (1 ml/kg body wt) and xylazine (0.5 ml/kg bw; E. Gräub
AG). To avoid intravascular clotting, a bolus of 5,000 IU heparin
was given before surgery. The chest and abdomen were opened
with a medial sternotomy, and the entire aorta from the heart to
the iliac bifurcation was excised and placed in cold (4
 
8
 
C) Krebs-
Ringer bicarbonate solution. The isolated aorta was cleaned of
adhering tissue under a dissection microscope (model M3C;
Wild AG).
All studies were performed on corresponding anatomical sites
of the aorta from each animal (unless otherwise stated, 
 
n 
 
5
 
 8 for
young and old rats, 
 
n 
 
5
 
 7 for middle-aged rats). All of the proce-
dures and experimental protocols were approved by the local au-
thorities for animal research (Commission for Animal Research
of the Canton of Zurich, Switzerland).
 
Organ Chambers
 
Rings of aorta 4–5 mm long were horizontally mounted be-
tween two stirrups in organ chambers filled with Krebs-Ringer
bicarbonate solution (pH 7.4, 37
 
8
 
C, 95% O
 
2
 
; 5% CO
 
2
 
) of the
following composition: NaCl (118.6 mmol/liter), KCl (4.7
mmol/liter), CaCl
 
2 
 
(2.5 mmol/liter), KH
 
2
 
PO
 
4 
 
(1.2 mmol/liter),
MgSO
 
4 
 
(1.2 mmol/liter), NaHCO
 
3 
 
(25.1 mmol/liter), glucose
(11.1 mmol/liter), calcium EDTA (0.026 mmol/liter). Isometric
tension was recorded continuously. After a 30-min equilibration
period, rings were gradually stretched (2 
 
g
 
) until the optimal ten-
sion–length relationship was reached as determined by the con-
traction to KCl (100 mmol/liter). Before the start of the experi-
ments, rings were allowed to equilibrate for another 30 min.
Vessels were preconstricted with 2–5 
 
3
 
 10
 
2
 
7
 
 mol/liter norepi-
nephrine until a stable plateau of 
 
z
 
70% of the contractile re-
sponse to KCl was reached. For endothelium-dependent relax-
ation, vessels were then relaxed with acetylcholine (10
 
2
 
10
 
–10
 
2
 
4
 
mol/liter) or calcium ionophore A23187 (10
 
2
 
10
 
–10
 
2
 
6
 
 mol/liter).
SNP (10
 
2
 
10
 
–10
 
2
 
5
 
 mol/liter) was used as an endothelium-inde-
pendent agonist.
 
Porphyrinic NO Microsensor
 
Direct in situ measurements of NO were carried out using a
three-electrode system: a porphyrinic NO microsensor as the
working electrode (anode), a platinum wire auxiliary electrode
(cathode), and a standard calomel reference electrode (8, 25).
Amperometric mode detection was used at a constant potential,
equal to the peak potential for NO oxidation of the working
electrode. The signal was detected in a current range of 10 
 
m
 
A
with a pulse height of 50 mV and a drop time of 0.5 s. The am-
perometric signal was recorded with a Kipp & Zonen chart re-
corder (Recom Electronic AG). Standard NO solutions (1.8 
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mmol/liter) were prepared from an aqueous solution saturated
with pure NO gas (Garbagas), and NO concentrations were cal-
culated using a calibration curve with an NO standard. Immedi-
ately before NO measurements, aortic rings of 3–4 mm length
were cut longitudinally and pinned on the bottom of an organ
chamber filled with fresh, phenol red–free, HBSS buffer (37
 
8
 
C,
pH 7.40). Then the active tip of the L-shaped porphyrinic NO
microsensor was placed on the endothelial surface using a preci-
sion stereo zoom microscope and a micromanipulator M3301
(World Precision Instruments). For maximal stimulation of
eNOS, calcium ionophore A23187 was injected into the organ
bath to yield a final concentration of 10
 
2
 
6
 
 mol/liter. A mean of at
least two independent determinations on two adjacent sections
was calculated for each animal.
 
Measurement of Superoxide
 
?
 
O
 
2
 
2
 
 concentration in aortic tissue was determined using a lu-
cigenin enhanced chemiluminescence method (26, 27). Each tis-
sue sample (5 mm length) was placed into 500 
 
m
 
l modified
Krebs-Ringer solution, pH 7.40, and prewarmed to 37
 
8
 
C for 1 h.
Immediately before measurement, rings were transferred into
scintillation vials filled with 500 
 
m
 
l Krebs-Hepes solution, pH
7.40, at room temperature. 12.5 
 
m
 
l lucigenin (bis-
 
N
 
-methylacri-
dinium nitrate; Sigma-Aldrich) was added to give a final concen-
tration of 250 
 
m
 
mol/liter. 
 
?
 
O
 
2
 
2
 
-generated chemiluminescence of
lucigenin was detected with a scintillation counter (Raytest PW
4700; Philips) connected to a Philips personal computer system.
The computer was programmed to measure 
 
?
 
O
 
2
 
2
 
 in defined time
intervals. 
 
?
 
O
 
2
 
2
 
 production by the tissue was calculated as the
mean of those last five values that did not differ by 
 
.
 
5% from
each other and was expressed as counts/(min 
 
3
 
 mg tissue). For
maximal stimulation, rings were incubated with 10
 
2
 
6
 
 mol/liter
calcium ionophore A23187. In some vessels, the endothelium
was mechanically removed 30 min before the experiment. All
measurements were performed on two or three aortic rings for
each animal, and the mean was calculated.
 
Determination of Total eNOS Protein Expression
 
For extraction of endothelial cells, a 1.5-cm-long segment of
freshly taken aorta was cut longitudinally and fixed on a gelati-
nated dish. The aorta was washed with RPMI medium (GIBCO
BRL), then incubated with collagenase at 37
 
8
 
C for 15 min, and
finally the endothelium was scraped off with a surgical blade. Af-
ter centrifugation at 5,000 rpm and 4
 
8
 
C for 5 min, the pellet was
homogenized in 100 
 
m
 
l Tris-SDS (2%) buffer followed by a 15-
min incubation on ice, a 1-min sonication in a water bath, and
subsequent boiling. Protein concentrations in the lysates were
measured using the bicinchoninic acid (BCA) Protein Assay Kit
(Pierce Chemical Co.). To ensure that equal amounts of proteins
were loaded in the gel, silver staining was performed using the
Silver Staining kit from Amersham Pharmacia Biotech. This visu-
alization technique has a sensitivity of 0.2 ng protein/band and is
100 times more sensitive than conventional Coomassie blue
staining. Proteins were separated on an SDS-6% polyacrylamide
gel at 40 V overnight. Separated proteins were transferred onto
an activated piece of polyvinylidine difluoride membrane (Im-
mobilon-P; Millipore) at 200 mA for 40 min. The membrane
was blocked with a buffer containing 5% milk powder, 20 mM
Tris-HCl (pH 7.50), 150 mM NaCl, and 0.05% Tween 20 for
1 h followed by three washes with Tris-buffered saline-Tween
(TBS-T). For Western blot analysis, membranes were incubated
with the primary monoclonal antibody (rabbit anti-NOS 3 IgG;
Santa Cruz Biotechnology, Inc.) in a dilution of 1:1,000 at room
temperature for 2 h. After washing, incubation with the second-
 
ary antibody (peroxidase-labeled anti–rabbit IgG, 1:1,000; Amer-
sham Pharmacia Biotech) followed at room temperature for 90
min. A control sample of human vein endothelial cells was run in
parallel as a positive control. Prestained markers (Bio-Rad Labo-
ratories) were used for molecular mass determinations. eNOS
protein was finally detected by enhanced chemiluminescence
(ECL; Amersham Pharmacia Biotech), and films were exposed
for 15 s.
 
Determination of Fractionated eNOS Protein Expression
 
Frozen aortic segments (5 mm length) were pulverized and
homogenized in a buffer (pH 7.40) containing 250 mM Tris-
HCl, 10 mM EDTA, and 10 mM EGTA. After centrifugation at
21,000 
 
g
 
 and 4
 
8
 
C for 5 min, the supernatant was transferred to
fresh microcentrifuge tubes. NOS in soluble and membrane-asso-
ciated fractions was separated by further centrifuging at 100,000 
 
g
for 60 min. The supernatant contains soluble NOS, whereas the
pellet, which is resuspended in homogenization buffer, contains
membrane-associated NOS. SDS-PAGE and Western blotting
were performed as described for total eNOS protein expression.
Films were exposed overnight.
NOS Activity Assay
Frozen aortic rings (5 mm length) were homogenized in 400
ml of a buffer containing 20 mmol/liter Hepes, 200 mmol/liter
sucrose, 1 mmol/liter dithiothreitol, 10 mg/ml soybean trypsin
inhibitor, 10 mg/ml leupeptin, and 2 mg/ml aprotinin. Before
sonication, PMSF at 0.1 mmol/liter final concentration and
[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate
(CHAPS; 20 mmol/liter) were added to homogenized samples.
Tissue homogenates of each age group of animals were pooled
according to protein content, and samples were measured in trip-
licates. Samples were then centrifuged at 45,000 rpm and 48C for
20 min. The supernatants were depleted of endogenous arginine
by passage over activated resin, and the protein concentration was
adjusted to 2.4 mg/ml. NOS activity was measured by the con-
version of l-[14C]arginine to l-[14C]citrulline and expressed as
pmol per mg protein per min (28). Cytosols from homogenized
samples (18 ml) were incubated at 378C for 20 min with 100 ml of
the optimized assay buffer for citrulline formation consisting of:
l-citrulline (1.2 mmol/liter), l-arginine (2 3 1022 mmol/liter),
NADPH (0.12 mmol/liter), tetrahydrobiopterin (1022 mmol/li-
ter), MgCl2 (1.2 mmol/liter), CaCl2 (0.24 mmol/liter), calmodu-
lin (40 U/ml), FAD (1023 mmol/liter), FMN (1023 mmol/liter),
and l-U[14C]arginine (1.2 3 1024 mmol/liter; 18.5 kBq/ml). In-
cubations were performed for each sample in the presence or ab-
sence of 1 mmol/liter EGTA to determine the amount of Ca21-
dependent and Ca21-independent formation of citrulline. The
NOS-specific and NOS-unspecific formation of citrulline was
determined in samples containing 1 mmol/liter L-NMMA. The
reaction was terminated by removal of substrate and addition of 1
ml (1:1, vol/vol) H2O/Dowex 50 3 8-400 cationic resin, pH
7.20, and 5 ml of water. After centrifugation of the incubation
mix for 3 min at 1,500 rpm, 4 ml supernatant in 10 ml scintillant
was examined for [14C]citrulline formation using a scintillation
counter.
MnSOD Protein Expression
Extraction. Aortic segments of 5 mm length were snap frozen
in liquid nitrogen immediately upon isolation. For SOD determi-
nation, aortas were homogenized and lysed in 200 ml Tris-SDS
(2%) buffer. After 1 h of incubation on ice and 4 min of sonica-
tion in a water bath, the suspension was boiled for 2 min and the
lysate centrifuged at 10,000 g at 48C for 10 min. Protein concen-1734 Peroxynitrite Formation in Vascular Aging
tration measurement and silver staining were performed as de-
scribed above.
Immunoprecipitation of MnSOD. 25  ml (z5  mg) solubilized
protein was diluted in 1 ml TBS (pH 7.50) and incubated with 10
ml primary antibody (rabbit anti-MnSOD IgG; room tempera-
ture, 2 h; StressGen Biotechnologies) with mixing by end over
end inversion. Immune complexes were precipitated with Pro-
tein G Plus Agarose (Santa Cruz Biotechnology Associates, Inc.)
after incubation with mixing at room temperature for 4 h and
centrifugation at 2,500 rpm (48C, 5 min). After washing once in
Tris saline azide (TSA, pH 8.0; 10 mM Tris, 140 mM NaCl,
0.025% NaN3) twice in APS-SDS Triton X-100, and once in 50
mM Tris-HCl (pH 6.80), immunoprecipitated proteins were di-
luted in sample buffer and boiled for 10 min. After centrifugation
at 10,000 rpm (room temperature, 1 min), the supernatant was
loaded on SDS-PAGE.
Western Blot Analysis of MnSOD. Proteins were separated on
15% SDS-polyacrylamide gels at 40 V overnight and transferred
electrophoretically onto polyvinylidine difluoride membranes
(Immobilon-P; Millipore) at 200 mA for 40 min. Membranes
were blocked with blocking buffer (as described above) for 1 h.
For detection of MnSOD, membranes were incubated with the
primary antibody (polyclonal rabbit anti-MnSOD IgG, dilution
1:2,000; StressGen Biotechnologies) at room temperature for 90
min. Nitrotyrosine-containing immunoprecipitated MnSOD was
detected by incubating membranes at room temperature for 90
min with a rabbit polyclonal IgG antinitrotyrosine antibody (di-
lution 1:2,000; Upstate Biotechnology). After three washes in
TBS-T, MnSOD membrane and immunocomplexes of MnSOD
and nitrotyrosine were incubated at room temperature for an ad-
ditional 90 min with a peroxidase-labeled anti–rabbit antibody
(Amersham Pharmacia Biotech). Membranes were washed three
times in TBS-T, and proteins were detected using enhanced
chemiluminescence (ECL; Amersham Pharmacia Biotech). Films
were exposed for 15 s to 3 min both for nitrotyrosine-containing
MnSOD and for MnSOD.
Determination of Inducible NOS Protein Expression
For inducible NOS (iNOS) determination, extraction was
performed as described above for MnSOD. Western blot analysis
was performed as described above for eNOS protein expression.
The primary monoclonal antibody (mouse anti-iNOS IgG;
Transduction Laboratories) was used in a dilution of 1:2,000, the
secondary antibody (peroxidase-labeled anti–mouse IgG; Amer-
sham Pharmacia Biotech) in a dilution of 1:4,000. The positive
control for iNOS was a mouse macrophage lysate (Transduction
Laboratories).
For all the molecular biology techniques, homogenates of all
animals belonging to one age group (young, n 5 8; middle-aged,
n 5 7; or old, n 5 8) were pooled according to protein content.
Protein concentrations in the lysates were measured, and silver
staining was performed to ensure that exactly the same amounts
of protein were loaded in the gels. All experiments were per-
formed at least three times and, unless otherwise stated, results
from one representative experiment are shown.
Quantification of Blots
Blots were densitometrically quantified using the public do-
main NIH Image 1.60 program developed at the National Insti-
tutes of Health (available at http://rsb.info.nih.gov/nih-image/).
In brief, after calibration of optical density, a density profile plot
Table I. Comparison of Different Parameters in Young, Middle-aged, and Old Rats
Parameter Young Middle-aged Old Significance level
Weight (g) 305 6 8* 537 6 7* 514 6 20** P , 0.0001 for Y vs. M and Y vs. O
Systolic RR (mmHg) 121 6 4 117 6 4 117 6 2N S
Heart rate (bpm) 334 6 13 323 6 14 344 6 13 NS
Maximal relaxations (%)
Ach 296 6 2* 289 6 2* 262 6 3** P , 0.0001 for Y vs. O and M vs. O
A23187 276 6 1* 274 6 4* 247 6 4** P , 0.0001 for Y vs. O and M vs. O
SNP 2111 6 2 2107 6 1 2105 6 1N S
Maximal NO release (nmol/liter) 690 6 50* 490 6 70* 200 6 30** P , 0.0001 for Y vs. O
*P , 0.001 for M vs. O
*P , 0.01 for M vs. Y
NOS activity (pmol/min/mg)
Total 120 6 13* 2 216 6 26** P , 0.01
eNOS 23 6 10** 2 144 6 14** **P , 0.001
iNOS 97 6 15 2 72 6 12 NS
Superoxide (cpm/mg dry wt)
Basal 2,302 6 323* 2,145 6 220* 6,058 6 445** P , 0.0001 for Y vs. O and M vs. O
Stimulated 82,495 6 6,033** 108,439 6 2,612 175,058 6 36,080** **P , 0.01
Y, young; M, middle-aged; O, old; RR, blood pressure; bpm, beats per minute.1735 van der Loo et al.
was generated for each band. Base lines and drop lines were
drawn manually so that each peak defined a closed area. The area
beneath the peaks was electronically calculated and expressed as
pixel intensity per unit area. Determinations of optical density
were performed on each band of at least three different blots.
Preparation of Tissue for Immunoelectron Microscopy
Two additional young and two additional old F1 rats belong-
ing to the cohorts from which the animals for all other experi-
ments had been chosen were used for immunoelectron micros-
copy. The aorta was isolated as described above and immediately
immersed into 4% formaldehyde (freshly prepared from para-
formaldehyde) in PBS (room temperature). Using an infusion
pump, the aorta was then perfused with the fixative at a constant
flow rate of 1.5 ml/min for 30 min. After two washes in PBS, the
aorta was kept in PBS containing 0.1% formaldehyde until fur-
ther processing for microscopy.
Immunoelectron Microscopy
Tissue was processed as described previously (29). In brief, seg-
ments of aorta were cryoprotected with 30% polypropylene gly-
col and quench frozen in melting propane cooled in liquid nitro-
gen. They were freeze substituted against 0.1% uranyl acetate in
methanol and embedded in Lowicryl HM20 at 2508C using a
Reichert automatic freeze-substitution unit (Leica). Thin sections
(50–60 nm) were cut using a Reichert Ultracut S ultramicrotome
(Leica), and mounted on carbon Formvar-coated nickel grids.
Sections were incubated with a 1:1,000 dilution of monoclonal
mouse antibody against nitrotyrosine (Upstate Biotechnology).
Control sections were incubated with either preimmune serum at
1:100 dilution or monoclonal mouse anti–human von Willebrand
factor (1:25). All incubations were done at 48C for 18 h. Primary
antibody binding sites were visualized with goat anti–mouse IgG
(H plus L)/10-nm gold conjugates (1 h, 48C; British BioCell In-
ternational). Sections were viewed with a CM100 transmission
electron microscope (Philips).
Calculations and Statistical Analysis
When applicable (comparison between two values), statistical
analysis was done by Student’s t test. For multiple comparisons,
results were analyzed by analysis of variance followed by Bonfer-
roni’s and Dunn’s correction (30). Data are presented as means 6
SEM. Means were considered significantly different at P , 0.05.
Results
Weight, Heart Rate, and Blood Pressure. Body weight
was higher in old and middle-aged rats than in young rats.
Systolic blood pressure and heart rate were not significantly
different between the three groups (Table I).
Age-dependent Impairment of NO-mediated Vascular Endo-
thelial Function. In old rats, NO-mediated, endothelium-
dependent relaxation to acetylcholine was markedly re-
duced compared with young and middle-aged rats (Fig. 1
A, and Table I). Furthermore, aging was also associated
with comparable reductions of NO-mediated, endothe-
lium-dependent relaxation to the calcium ionophore
A23187 (Fig. 1 B, and Table I). In contrast, there was no
impairment of endothelium-independent relaxation to
SNP in aged animals (Fig. 1 C, and Table I).
Age-associated Upregulation of the eNOS Enzyme System.
Fig. 2 A depicts typical amperograms for each age group of
direct in situ ex vivo measurements of NO on the aortic
endothelial surface after maximal stimulation with A23187
(1026 M). A receptor-independent agonist was chosen for
stimulation in order to delineate changes of eNOS activity
rather than possible age-associated changes of receptor-
mediated signal transduction. The porphyrinic microsen-
sor, with its fast response time (0.1–10 ms), high sensitivity
for NO, and lack of sensitivity to secondary species such as
nitrate/nitrite, was chosen to provide the most precise, di-
rect measurements of endogenous NO (25). Maximal NO
levels were lower in aortas obtained from old and middle-
aged animals compared with those from young rats (Fig. 2,
and Table I).
As NO in vascular endothelial cells is synthesized by
eNOS, we investigated the possibility that age-dependent
Figure 1. Age-dependent changes in endothelium-dependent and
-independent relaxation of the rat aorta. Line graphs showing concentra-
tion–response curves to acetylcholine (A), calcium ionophore A23187
(B), and SNP (C). Relaxation to both endothelium-dependent agonists
was reduced in old aortas (P , 0.0001). Endothelium-independent relax-
ation was unaffected by age. M/L, mol/liter.1736 Peroxynitrite Formation in Vascular Aging
changes might be related to alterations in the expression
and/or activity of the eNOS enzyme system. To this end,
we determined eNOS protein expression selectively in ho-
mogenates of endothelium using a new extraction method.
Strikingly, we found that eNOS protein expression steeply
increased in an age-dependent manner, nearly sevenfold in
old rats compared with young ones (Fig. 3) and nearly
threefold in middle-aged animals (young versus old, mid-
dle-aged versus old, and young versus middle-aged; P ,
0.0001). The age-dependent increase in eNOS expression
was in sharp contrast to the decrease in NO detection. In
contrast to eNOS, there was no iNOS expression detect-
able in all age groups (data not shown).
Analysis of the subcellular distribution of eNOS protein
expression revealed that, in all age groups, eNOS was ex-
clusively associated with the particulate, subcellular mem-
brane fraction (Fig. 4 A) containing the biological activity
of the enzyme (6, 7). No eNOS was found in the cytosolic
fraction.
To confirm that eNOS overexpression was also associ-
ated with a higher activity, we determined eNOS activity
by the conversion of l-[14C]arginine into l-[14C]citrulline.
Figure 2. Age-dependent changes in aortic NO release. (A) Representative
amperograms of NO release from isolated aortas. NO release was induced by
A23187 (1026 mol/liter) and measured in situ on the endothelial surface using a
porphyrinic microsensor. (B) Bar graph showing peak concentrations of NO.
Figure 3. eNOS expression in rat aorta. Homogenates of aortic endo-
thelium from young (lane 1), middle-aged (lane 2), and old (lane 3) rats
were separated by SDS-PAGE and analyzed by Western blotting for
eNOS expression. The position of the molecular mass markers is indi-
cated (expressed in kD). Human umbilical vein endothelial cells (lane 4)
were used as positive control.
Figure 4. (A) Subcellular analysis of eNOS as detected by immuno-
blotting. Membrane-associated (M) and cytosolic (C) eNOS expression.
Cytosolic and membrane fractions were prepared from homogenates of
each age group and analyzed by immunoblotting. Data are representative
of three experiments. HUVECs, human umbilical vein endothelial cells.
(B) Activity of total NOS and eNOS in aortas from young and old rats.
Activity was measured in homogenates of aortic tissue by determination
of the rate of conversion of l-[14C]arginine to l-[14C]citrulline. Signifi-
cance: total NOS, *P , 0.01; eNOS, **P , 0.001.1737 van der Loo et al.
Using this test we found that both total NOS activity and
eNOS activity were significantly greater in old than in
young rats (Fig. 4 B, and Table I). The sevenfold increase
in eNOS activity in old aortas parallels the increase in en-
zyme expression. In conclusion, fully active eNOS is up-
regulated with age, although the bioavailability of its in-
tended product, NO, is significantly diminished. However,
citrulline formation may not be stoichiometrically related to
NO production, as a partial conversion of NOS to its oxi-
dase form will also yield l-citrulline as an end product (31).
Age-associated Increased Vascular Superoxide Formation.
?O2
2 is the main oxidant for NO (32). Therefore, we in-
vestigated the possibility that increased tissue levels of ?O2
2
might be the cause of the inactivation of NO. Using a lu-
cigenin enhanced chemiluminescence method, we found a
threefold increase of basal and a twofold increase of stimu-
lated (A23187 1026 mol/liter) ?O2
2-generated chemilumi-
nescence in old aortas compared with young ones (Fig. 5
A, and Table I). This assay, in the absence of added
NADH, largely reflects ?O2
2 production.
To identify the source of ?O2
2, aortic rings were me-
chanically denuded. Thereafter, ?O2
2-generated chemilu-
minescence fell from 6,058 6 445 to 2,293 6 625 cpm/mg
(P 5 0.02), suggesting that the endothelium is the primary
source of ?O2
2 generation (Fig. 5 B). Values for young de-
nuded aortas (3,019 6 835 cpm/mg) did not significantly
differ from those obtained from young aortas with an intact
endothelium (2,302 6 323 cpm/mg; NS). This suggests
that in young aortas there is only a low, basal production of
superoxide and also that the age-associated increase in ?O2
2
occurs within the endothelium.
Increased Vascular Deposition of 3-Nitrotyrosinated Proteins in
Distinct Cellular and Subcellular Compartments of the Vascula-
ture. We then sought to prove that peroxynitrite was in-
deed formed after the capture of NO by ?O2
2 in the aging
vasculature and, if so, to clarify its biological effects on anti-
oxidative enzymes. Therefore, we studied the distribution
of 3-nitrotyrosine residues, which are typical end products
of the reaction of peroxynitrite with biological compounds.
As shown in Fig. 6, aortic tissue sections from old animals
exhibited a markedly increased specific immunostaining
with a monoclonal antibody to nitrotyrosine compared
with young animals. In the endothelium of old aortas (Fig.
6 A), significant amounts of nitrotyrosine accumulated in
the nucleus, the cytosol, and the mitochondria compared
with young aortas (Fig. 6 B). The extracellular matrix of
the intima (Fig. 6 E) and vascular smooth muscle cells
within the media (Fig. 6 G) of old aorta also had an en-
hanced immunolabeling compared with young tissue (Fig.
6, D and F, respectively). Quantification of immunogold
labeling for nitrotyrosine is shown in Fig. 7, A and B. De-
pending on the subcellular compartment examined, a two-
to sixfold increased labeling of old aorta was observed. A
particularly high labeling density for nitrotyrosine was
found in the mitochondria of endothelial cells. It is of im-
portance to note that these vessels do not exhibit any par-
ticular signs of atherosclerosis, as confirmed by electron mi-
croscopy.
Increased Nitration of MnSOD as a Molecular Marker for
Age-associated Mitochondrial Oxidative Stress in the Vascula-
ture. Immunoelectron microscopy strongly supported that
the most significant generation of oxidants, namely ?O2
2
and peroxynitrite, occurs within the mitochondria and in
particular, in those within the endothelium. This is of par-
ticular interest as, in a different pathophysiological context,
the nitration and inactivation of mitochondrial MnSOD
had been reported (22). Therefore, it was considered im-
portant that the effect of aging on this mitochondrial en-
zyme was analyzed further. Surprisingly, immunoblot anal-
ysis of aortic homogenates from different age groups with
polyclonal anti-MnSOD antibody revealed no significant
change in enzyme expression (Fig. 8 A). We then con-
firmed nitration of tyrosine residues in MnSOD by immu-
noblot analysis of MnSOD, which had been immunopre-
cipitated from aortic tissue with a polyclonal anti-MnSOD
antibody. Indeed, immunodetection with polyclonal anti-
nitrotyrosine antibody showed increased levels of tyrosine-
nitrated MnSOD in old and middle-aged aortas compared
with young ones (Fig. 8 B). Densitometric analysis of the
Western blots showed that nitration of MnSOD signifi-
cantly increased with age in old aortic tissue (Fig. 8 C). To
Figure 5. Age-dependent ?O2
2 production. (A) Bar graph showing
both basal amount of chemiluminescence generated by ?O2
2 in aorta
from young, middle-aged, and old rats (*P , 0.0001 versus basal values
for young and middle-aged rats) and maximal generation of chemilumi-
nescence after stimulation with calcium ionophore A23187 (1026 mol/li-
ter). (B) The influence of endothelium: aortic rings from young and old
(n 5 6 each) rats were mechanically denuded, and the basal chemilumi-
nescence signal was compared with that from intact aortas.1738 Peroxynitrite Formation in Vascular Aging
ensure that the same amounts of protein were loaded, a sil-
ver staining was performed before each Western blot analy-
sis (not shown).
Discussion
This study provides new insights into the mechanisms of
endothelial dysfunction that occur with age and offers a co-
herent picture of the underlying biochemical events. In
agreement with previous reports, we found that detectable
levels of NO were clearly reduced with age but, for the
first time, we demonstrate that decreased NO production is
a consequence neither of a reduced expression of the NO-
producing enzymes nor of a reduced activity in the l-argi-
nine/NO pathway, as both are sevenfold higher in aged
compared with young aortas. As this was accompanied by a
threefold higher activity in endothelial ?O2
2 production,
the age-associated, decreased endothelial NO levels, and
hence impaired vascular relaxation, must be a consequence
of the known rapid reaction between the two radicals. The
resulting formation of peroxynitrite is confirmed by en-
hanced vascular nitration. The conclusion that NO must be
inactivated by ?O2
2 is supported by three observations: (a)
in the old aorta, reduced NO levels occur in the presence
of increased eNOS expression and activity; (b) increased
?O2
2 levels with aging occur concomitantly with decreased
NO levels; and (c) ?O2
2 rapidly reacts with NO to form
peroxynitrite, and this reaction is reflected by tyrosine ni-
tration in proteins such as MnSOD.
Based on these new findings, we hypothesize an age-
related gradual change in a distinct network of different sig-
nals, including up- and/or downregulation which controls
vascular function. Mitochondria and an increased one-elec-
tron oxidation of respiratory chain components may be in-
volved in the initial reactions. As a consequence, the pro-
tective mechanisms that preserve endothelial function are
dramatically “switched on” (i.e., upregulation of the eNOS
enzyme system), but the balance between vascular protec-
Figure 6. The accumulation of 3-nitro-
tyrosine is increased in the aorta of the old
rat compared with that of the young rat.
Representative electron micrographs show
the pattern of immunogold labeling for
3-nitrotyrosine in thin sections of young
(B, D, and F) and old (A, E, and G) aortas.
Primary antibody binding sites were visual-
ized with goat anti–mouse IgG conjugated
to 10-nm gold particles. (A) Intima of the
aorta from an old rat. Label is densest over
mitochondria (m) and strong over nucleo-
plasm (n) and over endothelial cell cyto-
plasm. Sparse labeling is associated with the
luminal plasmalemma (large arrowheads)
and stronger label is present over the ablu-
minal plasmalemma (small arrowheads).
Strong labeling is seen in the subendothelial
space (se). (B) Intima of the aorta from a
young rat. Label is lower over mitochon-
dria and cytoplasm and sparse over the lu-
minal plasmalemma (large arrowhead) and
the abluminal plasmalemma (small arrow-
head). (C) Intima of an old rat. The pri-
mary antisera against nitrotyrosine was pre-
incubated with 20 mmol/liter nitrotyrosine
for 1 h before labeling as in A and B. Label
density is reduced to levels lower than those
seen in the young rats in all compartments.1739 van der Loo et al.
tion and damage cannot be preserved, as it is in young
animals. As the functional responses to the receptor-depen-
dent and -independent endothelium-dependent vaso-
dilators acetylcholine and A23187, respectively, were su-
perimposable, age-associated endothelial dysfunction is not
related to an alteration of the signal transduction pathway,
but instead to reduced bioavailability of NO.
Paradoxically, both eNOS protein expression and
l-arginine turnover were increased sevenfold in aortas
from old animals. Previous work demonstrated a marginal
increase in eNOS protein expression, but not activity, in
the aorta of 20-mo-old male Wistar rats (9). The increase
described here is much more dramatic and might be due to
the considerably higher age of the animals used in this
study and to our new technique for the isolation of vascu-
lar endothelium. In addition, we found that eNOS activity
was similarly increased, demonstrating the functional in-
tegrity and in fact overactivity of the l-arginine/NO path-
way even at extreme age. This conclusion is further
strengthened by the subcellular distribution of eNOS. As-
sociation of eNOS with the cell membrane determines the
biological activity of the enzyme, and its location in caveo-
lae may facilitate NO signaling to adjacent smooth muscle
cells (7). It is likely that the eNOS enzyme system is over-
activated in aged blood vessels as a compensatory mecha-
nism to counterbalance endothelial dysfunction induced by
age-dependent oxidative stress. Another reason for in-
creased eNOS expression might be hemodynamic forces
such as shear stress, which have been shown to upregulate
eNOS in vitro (33). However, neither blood pressure,
heart rate, nor hematocrit value changed with age in these
animals. In contrast to eNOS, there was no significant dif-
ference in both iNOS activity and expression between
young and old animals, suggesting that iNOS does not
contribute to the compensatory mechanism of NOS up-
regulation.
The major and crucial finding of this study is the mark-
edly increased ?O2
2 production (most of which was de-
rived from the endothelium) with aging. The use of lucige-
nin to detect ?O2
2 in tissue has recently become a subject
(D) Intima of a young rat showing low levels of
labeling over the endothelium (e) and sparse la-
beling over the subendothelial space and the
first elastic lamellae (l). (E) Subendothelial
space and the first elastic lamellae of an old rat.
Labeling density is much greater in both com-
partments and is particularly dense over aggre-
gates of electron dense material seen in the sub-
endothelial space. (F) Smooth muscle cell in
the medial layer of the aorta of a young rat. La-
bel is strongest over the cytoplasm (c) and low
over the nucleoplasm and extracellular space
(ec) and seldom seen over the sarcolemma (ar-
rowhead). (G) Smooth muscle cell in the me-
dial layer of the aorta from an old rat. Labeling
is much stronger over the cytoplasm and is fre-
quently seen over the sarcolemma (arrow-
heads). Bars, 0.5 mm. Original magnifications:
322,000.
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of controversy, as lucigenin may itself enhance ?O2
2 for-
mation (34, 35). However, if autoxidation of lucigenin had
in part contributed to ?O2
2 generation, this would have
been applicable to the same extent to all age groups and
would not affect the relative differences observed.
The increased ?O2
2 production led to an inactivation of
equimolar amounts of NO by the formation of peroxyni-
trite, which, in turn, exhibits new messenger functions.
The highest density of immunogold labeling for 3-nitroty-
rosyl was found in the mitochondria, in particular in those
within the endothelium, indicating that nitrotyrosination
was dominant in these organelles and supporting their im-
portance in the cascade of events contributing to the aging
process. This may well have distinct pathophysiological
consequences. Although we did not directly investigate
mitochondria, it is reasonable to assume that mitochondria
themselves may be a major source of ?O2
2 and peroxyni-
trite in the aging vascular system (36). Autoxidation of
components of the respiratory chain would lead to the for-
mation of ?O2
2, which is the one-electron reduction prod-
uct of oxygen. Increased ?O2
2 production is unsuccessfully
counter-balanced by the enhanced expression and activity
of NO-synthesizing enzymes. At least in the chronic pro-
cess of vascular aging, this directly involves eNOS but not
iNOS, although in situations of acute oxidative stress,
iNOS may also be induced (37).
Peroxynitrite nitrates an essential tyrosine residue in Mn-
SOD with the participation of manganese catalysis. In fact,
Figure 7. Quantitative analysis of immunogold labeling for 3-nitroty-
rosines in young and old aortas in endothelium (A) and intima/media (B).
Two sections were prepared from randomly selected areas of each aorta
(see Materials and Methods). On each section, 15 fields of endothelium,
intima, and media were randomly chosen. In each area of endothelium,
immunogold labeling density was estimated over heterochromatin (1),
euchromatin (2), cytosol (3), and mitochondria (4). In the intima, immu-
nogold labeling was also estimated over the subendothelial space (1) and
the elastic lamellae (2). In the media, immunogold labeling density was
estimated over the cytosol (3) and mitochondria (4). All data are pre-
sented as means of the labeling density in each region of each of two sec-
tions from each aorta.
Figure 8. Total protein expression and age-associated increased nitra-
tion of mitochondrial MnSOD. Western blot of MnSOD (A) from young
(lane 1), middle-aged (lane 2), and old (lane 3) aortas. Extracted proteins
were separated on 15% SDS-PAGE gels and examined by Western blot
with a polyclonal antibody against MnSOD. Recombinant MnSOD
served as a positive control (lane 4). Molecular weight markers are indi-
cated (in kD) on the left. (B) Nitrotyrosine-containing immunoprecipi-
tated MnSOD from young (lane 1), middle-old (lane 2), and old (lane 3)
rats were separated by 15% SDS-PAGE gels and analyzed by Western blot
with a polyclonal antibody against nitrotyrosine. Films were exposed for
15 s to 3 min. (C) Quantitative analysis of tyrosine-nitrated MnSOD.1741 van der Loo et al.
our results suggest that the nitration of tyrosine within Mn-
SOD might be a mechanism leading to a significant reduc-
tion of its activity (38), and a possible further increase of
?O2
2 formation. Nitration and dityrosine formation, both
of which can easily be mediated by peroxynitrite, are both
required to completely inhibit MnSOD. However, a partial
inhibition of this crucial enzyme may also have important
biological consequences (MacMillan-Crow, L.A., personal
communication). MnSOD is the major antioxidant enzyme
in the mitochondria of all mammals, and it is an endoge-
nous nitration target in human renal allograft rejection (22).
This study is the first to suggest that the degree of nitration
of this enzyme may also be a molecular footprint of vascu-
lar aging. Proof for a pivotal role of MnSOD is provided by
a recent report showing that genetic inactivation of Mn-
SOD in mutant mice results in premature death (39), and
that treatment with the SOD mimetic manganese–tetrakis-
benzoic acid-porphyrin (MnTBAP) dramatically prolongs
their survival. Manganese porphyrins also have a high ca-
pacity for the elimination of peroxynitrite (40). Our find-
ings suggest that mitochondrial MnSOD may be a poten-
tially important and novel drug target for the alleviation of
vascular aging. It is of particular interest to the design of fu-
ture therapeutic strategies to combat nitration-associated
vascular aging to note that manganese porphyrins become
even more efficient reductases for peroxynitrite when cou-
pled with the biological antioxidants vitamin C, vitamin E,
and glutathione, all of which serve as electron sources for
the reduction of peroxynitrite (40).
Although 3-nitrotyrosyl labeling would be in line with a
mitochondrial source of ?O2
2, other sources, such as
NADPH-oxidase (41), xanthin oxidase, or eNOS (42) it-
self, also have to be considered as contributors to ?O2
2 and
peroxynitrite formation. eNOS, in the absence of cofactors
such as tetrahydrobiopterin, or in case of insufficient sub-
strate supply, will exhibit oxidase activity (31). The dra-
matic increase in activity and expression of eNOS seen in
the aged aorta may eventually not (or not only) be benefi-
cial as an attempt by the organism to maintain endothelial
function, but rather be detrimental, with eNOS becoming
part of a redox system that increases electron transfer to ox-
ygen. However, attempts to identify eNOS as the enzy-
matic source of ?O2
2 will be hampered by the fact that se-
lective inhibitors of its oxidase activity are not available to
date. It remains to be determined whether eNOS plays a
more pathological or a more protective role in vascular
aging.
As eNOS expression and citrulline formation from
l-arginine are dramatically increased with age, the dimin-
ished formation of free NO must be primarily a conse-
quence of augmented ?O2
2 generation. The link between
increased ?O2
2 production and decreased NO release is
stringent in view of the known chemistry, kinetics, and
diffusion properties of both free radicals. This reaction is
currently accepted as the main biological source of perox-
ynitrite responsible for tyrosine nitration (43, 44). This
would also be in agreement with our measurements of
?O2
2 and nitrated proteins. Future work will be concerned
with the identification of nitrotyrosinated prostacyclin syn-
thase, the only other enzyme for which nitration by reac-
tion with peroxynitrite and subsequent inactivation has
been reported (45), and which has been associated with en-
dothelial dysfunction in atherosclerosis (21) and ischemia-
reperfusion damage (46).
The analysis presented here sets the basis for future stud-
ies in the field of vascular aging, in particular for those
aimed at preventing age-related vascular dysfunction. Based
on the knowledge of the mechanisms involved in the aging
process of the endothelium, which is crucial to maintain
normal vascular function, strategies to prevent this process
should be designed and tested. New therapeutic interven-
tions to prevent vascular aging might have enormous med-
ical consequences given the strong age dependency of car-
diovascular diseases.
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